Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0648 Transporter Info
Gene Name	ATP7A
Transporter Name	Copper-transporting ATPase 1
Gene ID	538
UniProt ID	Q04656

Post-Translational Modification of This DT
Overview of ATP7A Modification Sites with Functional and Structural Information
Sequence	M D P S M G V N S V T I S V E G M T C N S C V W T I E Q Q I G K V N G V H H I K V S L E E K N A T I I Y D P K L Q T P K T L Q E A I D D M G F D A V I H N P D P L P V L T D T L F L T V T A S L T L P W D H I Q S T L L K T K G V T D I K I Y P Q K R T V A V T I I P S I V N A N Q I K E L V P E L S L D T G T L E K K S G A C E D H S M A Q A G E V V L K M K V E G M T C H S C T S T I E G K I G K L Q G V Q R I K V S L D N Q E A T I V Y Q P H L I S V E E M K K Q I E A M G F P A F V K K Q P K Y L K L G A I D V E R L K N T P V K S S E G S Q Q R S P S Y T N D S T A T F I I D G M H C K S C V S N I E S T L S A L Q Y V S S I V V S L E N R S A I V K Y N A S S V T P E S L R K A I E A V S P G L Y R V S I T S E V E S T S N S P S S S S L Q K I P L N V V S Q P L T Q E T V I N I D G M T C N S C V Q S I E G V I S K K P G V K S I R V S L A N S N G T V E Y D P L L T S P E T L R G A I E D M G F D A T L S D T N E P L V V I A Q P S S E M P L L T S T N E F Y T K G M T P V Q D K E E G K N S S K C Y I Q V T G M T C A S C V A N I E R N L R R E E G I Y S I L V A L M A G K A E V R Y N P A V I Q P P M I A E F I R E L G F G A T V I E N A D E G D G V L E L V V R G M T C A S C V H K I E S S L T K H R G I L Y C S V A L A T N K A H I K Y D P E I I G P R D I I H T I E S L G F E A S L V K K D R S A S H L D H K R E I R Q W R R S F L V S L F F C I P V M G L M I Y M M V M D H H F A T L H H N Q N M S K E E M I N L H S S M F L E R Q I L P G L S V M N L L S F L L C V P V Q F F G G W Y F Y I Q A Y K A L K H K T A N M D V L I V L A T T I A F A Y S L I I L L V A M Y E R A K V N P I T F F D T P P M L F V F I A L G R W L E H I A K G K T S E A L A K L I S L Q A T E A T I V T L D S D N I L L S E E Q V D V E L V Q R G D I I K V V P G G K F P V D G R V I E G H S M V D E S L I T G E A M P V A K K P G S T V I A G S I N Q N G S L L I C A T H V G A D T T L S Q I V K L V E E A Q T S K A P I Q Q F A D K L S G Y F V P F I V F V S I A T L L V W I V I G F L N F E I V E T Y F P G Y N R S I S R T E T I I R F A F Q A S I T V L C I A C P C S L G L A T P T A V M V G T G V G A Q N G I L I K G G E P L E M A H K V K V V V F D K T G T I T H G T P V V N Q V K V L T E S N R I S H H K I L A I V G T A E S N S E H P L G T A I T K Y C K Q E L D T E T L G T C I D F Q V V P G C G I S C K V T N I E G L L H K N N W N I E D N N I K N A S L V Q I D A S N E Q S S T S S S M I I D A Q I S N A L N A Q Q Y K V L I G N R E W M I R N G L V I N N D V N D F M T E H E R K G R T A V L V A V D D E L C G L I A I A D T V K P E A E L A I H I L K S M G L E V V L M T G D N S K T A R S I A S Q V G I T K V F A E V L P S H K V A K V K Q L Q E E G K R V A M V G D G I N D S P A L A M A N V G I A I G T G T D V A I E A A D V V L I R N D L L D V V A S I D L S R K T V K R I R I N F V F A L I Y N L V G I P I A A G V F M P I G L V L Q P W M G S A A M A A S S V S V V L S S L F L K L Y R K P T Y E S Y E L P A R S Q I G Q K S P S E I S V H V G I D D T S R N S P K L G L L D R I V N Y S R A S I N S L L S D K R S L N S V V T S E P D K H S L L V G D F R E D D D T A L
PTM type	X-Acetylation X-N-glycosylation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation
Lysine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP7A			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	226
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ATP7A Lysine 226 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ATP7A			[2]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	227
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ATP7A Lysine 227 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ATP7A			[3]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	239
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ATP7A Lysine 239 has the potential to affect its expression or activity.
N-glycosylation
Asparagine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP7A			[4]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	686
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ATP7A Asparagine 686 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ATP7A			[4]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	975
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ATP7A Asparagine 975 has the potential to affect its expression or activity.
Unclear Residue	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP7A			[5]
Role of PTM	Potential impacts
Affected Drug/Substrate	Copper	Results for Drug	Affecting the inward transport of copper
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at ATP7A has the potential to affect its expression or activity.
Phosphorylation
Serine	47 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP7A			[5]
Role of PTM	Potential impacts
Affected Drug/Substrate	Copper	Results for Drug	Affecting the inward transport of copper
Modified Residue	Serine
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ATP7A			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	147
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 147 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ATP7A			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	262
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 262 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ATP7A			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	263
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 263 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ATP7A			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	266
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 266 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ATP7A			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	270
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 270 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ATP7A			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	272
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 272 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ATP7A			[6] , [11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	277
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 277 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ATP7A			[12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	316
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 316 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ATP7A			[6] , [11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	324
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 324 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ATP7A			[6] , [11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	325
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 325 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence ATP7A			[6] , [11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	330
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 330 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence ATP7A			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	339
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 339 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence ATP7A			[6] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	346
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 346 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence ATP7A			[10] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	349
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 349 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence ATP7A			[13] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	353
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 353 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence ATP7A			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	355
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 355 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence ATP7A			[10] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	357
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 357 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence ATP7A			[10] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	359
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 359 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence ATP7A			[13] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	360
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 360 has the potential to affect its expression or activity.
PTM Phenomenon 21	Have the potential to influence ATP7A			[13] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	361
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 361 has the potential to affect its expression or activity.
PTM Phenomenon 22	Have the potential to influence ATP7A			[10] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	362
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 362 has the potential to affect its expression or activity.
PTM Phenomenon 23	Have the potential to influence ATP7A			[17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	372
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 372 has the potential to affect its expression or activity.
PTM Phenomenon 24	Have the potential to influence ATP7A			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	427
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 427 has the potential to affect its expression or activity.
PTM Phenomenon 25	Have the potential to influence ATP7A			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	445
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 445 has the potential to affect its expression or activity.
PTM Phenomenon 26	Have the potential to influence ATP7A			[20]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	630
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 630 has the potential to affect its expression or activity.
PTM Phenomenon 27	Have the potential to influence ATP7A			[18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	639
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 639 has the potential to affect its expression or activity.
PTM Phenomenon 28	Have the potential to influence ATP7A			[21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	761
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 761 has the potential to affect its expression or activity.
PTM Phenomenon 29	Have the potential to influence ATP7A			[17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1146
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 1146 has the potential to affect its expression or activity.
PTM Phenomenon 30	Have the potential to influence ATP7A			[22]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1157
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 1157 has the potential to affect its expression or activity.
PTM Phenomenon 31	Have the potential to influence ATP7A			[22]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1158
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 1158 has the potential to affect its expression or activity.
PTM Phenomenon 32	Have the potential to influence ATP7A			[23]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1245
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 1245 has the potential to affect its expression or activity.
PTM Phenomenon 33	Have the potential to influence ATP7A			[23]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1258
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 1258 has the potential to affect its expression or activity.
PTM Phenomenon 34	Have the potential to influence ATP7A			[17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1417
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 1417 has the potential to affect its expression or activity.
PTM Phenomenon 35	Have the potential to influence ATP7A			[8] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1430
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 1430 has the potential to affect its expression or activity.
PTM Phenomenon 36	Have the potential to influence ATP7A			[8] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1432
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 1432 has the potential to affect its expression or activity.
PTM Phenomenon 37	Have the potential to influence ATP7A			[10] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1435
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 1435 has the potential to affect its expression or activity.
PTM Phenomenon 38	Have the potential to influence ATP7A			[10] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1444
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 1444 has the potential to affect its expression or activity.
PTM Phenomenon 39	Have the potential to influence ATP7A			[10] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1447
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 1447 has the potential to affect its expression or activity.
PTM Phenomenon 40	Have the potential to influence ATP7A			[8] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1460
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 1460 has the potential to affect its expression or activity.
PTM Phenomenon 41	Have the potential to influence ATP7A			[8] , [24]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1463
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 1463 has the potential to affect its expression or activity.
PTM Phenomenon 42	Have the potential to influence ATP7A			[8] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1466
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 1466 has the potential to affect its expression or activity.
PTM Phenomenon 43	Have the potential to influence ATP7A			[8] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1469
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 1469 has the potential to affect its expression or activity.
PTM Phenomenon 44	Have the potential to influence ATP7A			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1473
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 1473 has the potential to affect its expression or activity.
PTM Phenomenon 45	Have the potential to influence ATP7A			[6] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1476
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 1476 has the potential to affect its expression or activity.
PTM Phenomenon 46	Have the potential to influence ATP7A			[6] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1480
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 1480 has the potential to affect its expression or activity.
PTM Phenomenon 47	Have the potential to influence ATP7A			[6] , [25]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1486
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Serine 1486 has the potential to affect its expression or activity.
Threonine	28 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP7A			[20]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	58
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 58 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ATP7A			[10] , [14]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	150
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 150 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ATP7A			[8] , [10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	152
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 152 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ATP7A			[6] , [9]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	274
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 274 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ATP7A			[6] , [10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	278
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 278 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ATP7A			[6] , [11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	280
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 280 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ATP7A			[8] , [24]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	327
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 327 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ATP7A			[6] , [13]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	348
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 348 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ATP7A			[13] , [14]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	354
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 354 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ATP7A			[17]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	376
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 376 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ATP7A			[26] , [27]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	426
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 426 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence ATP7A			[26] , [27]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	430
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 430 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence ATP7A			[10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	447
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 447 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence ATP7A			[10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	465
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 465 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence ATP7A			[10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	467
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 467 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence ATP7A			[28] , [29]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	476
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 476 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence ATP7A			[21]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	743
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 743 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence ATP7A			[21]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	754
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 754 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence ATP7A			[21]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	755
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 755 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence ATP7A			[30]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1046
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 1046 has the potential to affect its expression or activity.
PTM Phenomenon 21	Have the potential to influence ATP7A			[30]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1048
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 1048 has the potential to affect its expression or activity.
PTM Phenomenon 22	Have the potential to influence ATP7A			[30]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1050
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 1050 has the potential to affect its expression or activity.
PTM Phenomenon 23	Have the potential to influence ATP7A			[30]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1053
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 1053 has the potential to affect its expression or activity.
PTM Phenomenon 24	Have the potential to influence ATP7A			[23]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1254
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 1254 has the potential to affect its expression or activity.
PTM Phenomenon 25	Have the potential to influence ATP7A			[17]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1414
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 1414 has the potential to affect its expression or activity.
PTM Phenomenon 26	Have the potential to influence ATP7A			[10] , [13]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1443
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 1443 has the potential to affect its expression or activity.
PTM Phenomenon 27	Have the potential to influence ATP7A			[6] , [13]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1479
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 1479 has the potential to affect its expression or activity.
PTM Phenomenon 28	Have the potential to influence ATP7A			[20]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1498
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Threonine 1498 has the potential to affect its expression or activity.
Tyrosine	12 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP7A			[6] , [10]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	273
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Tyrosine 273 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ATP7A			[12] , [27]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	321
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Tyrosine 321 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ATP7A			[28] , [31]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	343
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Tyrosine 343 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ATP7A			[10] , [32]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	471
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Tyrosine 471 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ATP7A			[33]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	517
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Tyrosine 517 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ATP7A			[21]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	760
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Tyrosine 760 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ATP7A			[21]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	770
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Tyrosine 770 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ATP7A			[22]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1178
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Tyrosine 1178 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ATP7A			[17]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1410
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Tyrosine 1410 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ATP7A			[17]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1415
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Tyrosine 1415 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ATP7A			[17]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1418
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Tyrosine 1418 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence ATP7A			[6] , [13]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1459
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP7A Tyrosine 1459 has the potential to affect its expression or activity.
Ubiquitination
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP7A			[34]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	333
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ATP7A Lysine 333 has the potential to affect its expression or activity.

References
1	Zero gravity for burn patients and paraplegics?. Ann Plast Surg. 1980 Dec;5(6):503.
2	Esophagoplasty for esophageal cancer by transplantation of an isoperistaltic small intestine loop in Y into the neck (author's transl). Ann Chir. 1980;34(6):396-9.
3	Gastric carcinoma. Therapy and prognosis. A report of a surgical series of 235 cases (author's transl). Ann Chir. 1981 Jan;35(1):27-32.
4	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: ATP7A_HUMAN)
5	Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes. J Med Genet. 2007 Nov;44(11):673-88.
6	A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
7	Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
8	UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
9	Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target. Nat Commun. 2018 Sep 11;9(1):3679.
10	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
11	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
12	A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.
13	An orthogonal proteomic survey uncovers novel Zika virus host factors. Nature. 2018 Sep;561(7722):253-257.
14	Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
15	Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer. PLoS One. 2018 Oct 2;13(10):e0204658.
16	Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat Commun. 2019 Jan 10;10(1):104.
17	An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
18	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
19	Isoelectric point-based fractionation by HiRIEF coupled to LC-MS allows for in-depth quantitative analysis of the phosphoproteome. Sci Rep. 2017 Jul 3;7(1):4513.
20	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
21	Sequential enrichment with titania-coated magnetic mesoporous hollow silica microspheres and zirconium arsenate-modified magnetic nanoparticles for the study of phosphoproteome of HL60 cells. J Chromatogr A. 2014 Oct 24;1365:54-60.
22	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
23	Phosphoproteins in extracellular vesicles as candidate markers for breast cancer. Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3175-3180.
24	Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
25	Modulation of Cl- signaling and ion transport by recruitment of kinases and phosphatases mediated by the regulatory protein IRBIT. Sci Signal. 2018 Oct 30;11(554):eaat5018.
26	Phosphoproteomic analysis identifies the tumor suppressor PDCD4 as a RSK substrate negatively regulated by 14-3-3. Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):E2918-27.
27	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
28	Comparative phosphoproteomic analysis reveals signaling networks regulating monopolar and bipolar cytokinesis. Sci Rep. 2018 Feb 2;8(1):2269.
29	Specificity of Phosphorylation Responses to Mitogen Activated Protein (MAP) Kinase Pathway Inhibitors in Melanoma Cells. Mol Cell Proteomics. 2018 Apr;17(4):550-564.
30	Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
31	Phosphoproteomic Analysis of Aurora Kinase Inhibition in Monopolar Cytokinesis. J Proteome Res. 2015 Sep 4;14(9):4087-98.
32	Neuroblastoma tyrosine kinase signaling networks involve FYN and LYN in endosomes and lipid rafts. PLoS Comput Biol. 2015 Apr 17;11(4):e1004130.
33	Signaling networks assembled by oncogenic EGFR and c-Met. Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):692-7.
34	Proteome-wide identification of ubiquitylation sites by conjugation of engineered lysine-less ubiquitin. J Proteome Res. 2012 Feb 3;11(2):796-807.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence